Insider Transactions Reported by 9 Insiders of Transcode Therapeutics, Inc.

Symbol
RNAZ on Nasdaq
Location
Boston, MA

There are no Buy or Sell transactions made by insiders since 29 Jan 2025

Transcode Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anna Moore 10%+ Owner $791,920 08 Jul 2021
Robert Michael Dudley Chief Executive Officer, Director $91,934 28 Sep 2023
Thomas A. Fitzgerald Interim CEO, CFO, Director $28,722 14 Jun 2024
Magda Marquet Director 14 Jun 2024
JACK E. STOVER Director 19 Dec 2025
Philippe Calais Director 14 Jun 2024
ELIZABETH CZEREPAK Director 06 Oct 2025
Zdravka Medarova Chief Technology Officer, 10%+ Owner 12 Dec 2022
Erik Manting Director 14 Jun 2024

Recent Insider Transactions by Companies or Individuals for Transcode Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.